Lite Strategy, Inc. Operating Expenses
Lite Strategy, Inc. (LITS) reported Operating Expenses of $21.00 million for the 12-month period ending 2016-06-30, per its 10-K filed 2016-09-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-09-06
- Lite Strategy, Inc. operating expenses for the quarter ending 2016-06-30 was $5.82M, a 2.34% increase year-over-year.
- Lite Strategy, Inc. operating expenses for the quarter ending 2016-03-31 was $5.41M, a 39.62% decline year-over-year.
- Lite Strategy, Inc. operating expenses for the quarter ending 2015-12-31 was $5.13M, a 43.77% decline year-over-year.
- Lite Strategy, Inc. operating expenses for the quarter ending 2015-09-30 was $4.65M, a 48.41% decline year-over-year.
- Lite Strategy, Inc. operating expenses for fiscal 2016 was $21.00M, a 35.91% decline from fiscal 2015.
- Lite Strategy, Inc. operating expenses for fiscal 2015 was $32.77M, a 20.36% increase from fiscal 2014.
- Lite Strategy, Inc. operating expenses for fiscal 2014 was $27.23M, a 142.63% increase from fiscal 2013.
- Lite Strategy, Inc. operating expenses for fiscal 2013 was $11.22M, a 33.69% increase from fiscal 2012.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 130 month | Operating Expenses 133 month | Operating Expenses 136 month | Operating Expenses 139 month | Operating Expenses 142 month | Operating Expenses 145 month | Operating Expenses 148 month | Operating Expenses 151 month | Operating Expenses 154 month | Operating Expenses 157 month | Operating Expenses 160 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | $11.23M derived: sum of 2 quarters · filed 2016-09-06 | $16.36M derived: sum of 3 quarters · filed 2016-09-06 | $21.00M 10-K · filed 2016-09-06 | |||||||||||
| 2016-03-31 | $5.41M 10-Q · filed 2016-05-05 | $10.54M derived: sum of 2 quarters · filed 2016-05-05 | $15.18M 10-Q · filed 2016-05-05 | $20.87M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2015-12-31 | $5.13M 10-Q · filed 2016-02-05 | $9.77M 10-Q · filed 2016-02-05 | $15.46M derived: sum of 3 quarters · filed 2016-09-06 | $24.42M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2015-09-30 | $4.65M 10-Q · filed 2015-11-06 | $10.33M derived: sum of 2 quarters · filed 2016-09-06 | $19.29M derived: sum of 3 quarters · filed 2016-09-06 | $28.41M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2015-06-30 | $5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | $14.65M derived: sum of 2 quarters · filed 2016-09-06 | $23.77M derived: sum of 3 quarters · filed 2016-09-06 | $32.77M 10-K · filed 2016-09-06 | |||||||||||
| 2015-03-31 | $8.96M 10-Q · filed 2016-05-05 | $18.08M derived: sum of 2 quarters · filed 2016-05-05 | $27.08M 10-Q · filed 2016-05-05 | $35.64M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2014-12-31 | $9.12M 10-Q · filed 2016-02-05 | $18.12M 10-Q · filed 2016-02-05 | $26.68M derived: sum of 3 quarters · filed 2016-09-06 | $34.09M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2014-09-30 | $9.01M 10-Q · filed 2015-11-06 | $17.56M derived: sum of 2 quarters · filed 2016-09-06 | $24.97M derived: sum of 3 quarters · filed 2016-09-06 | $31.32M derived: sum of 4 quarters · filed 2016-09-06 | |||||||||||
| 2014-06-30 | $8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | $15.96M derived: sum of 2 quarters · filed 2016-09-06 | $22.31M derived: sum of 3 quarters · filed 2016-09-06 | $27.23M 10-K · filed 2016-09-06 | |||||||||||
| 2014-03-31 | $7.41M 10-Q · filed 2015-05-07 | $13.76M derived: sum of 2 quarters · filed 2015-05-07 | $18.67M 10-Q · filed 2015-05-07 | $21.90M derived: sum of 4 quarters · filed 2015-09-02 | $118.27M 10-Q · filed 2014-05-08 | ||||||||||
| 2013-12-31 | $6.35M 10-Q · filed 2015-02-06 | $11.26M 10-Q · filed 2015-02-06 | $14.49M derived: sum of 3 quarters · filed 2015-09-02 | $17.26M derived: sum of 4 quarters · filed 2015-09-02 | $110.86M 10-Q · filed 2014-02-11 | ||||||||||
| 2013-09-30 | $4.91M 10-Q · filed 2014-11-06 | $8.14M derived: sum of 2 quarters · filed 2015-09-02 | $10.91M derived: sum of 3 quarters · filed 2015-09-02 | $13.67M derived: sum of 4 quarters · filed 2015-09-02 | $104.51M 10-Q · filed 2013-11-08 | ||||||||||
| 2013-06-30 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-02 | $6.00M derived: sum of 2 quarters · filed 2015-09-02 | $8.76M derived: sum of 3 quarters · filed 2015-09-02 | $11.22M 10-K · filed 2015-09-02 | $99.60M 10-K · filed 2013-09-18 | ||||||||||
| 2013-03-31 | $2.77M 10-Q · filed 2014-05-08 | $5.52M derived: sum of 2 quarters · filed 2014-05-08 | $7.99M 10-Q · filed 2014-05-08 | $10.19M derived: sum of 4 quarters · filed 2014-09-09 | $96.36M 10-Q · filed 2013-05-09 | ||||||||||
| 2012-12-31 | $2.76M 10-Q · filed 2014-02-11 | $5.22M 10-Q · filed 2014-02-11 | $7.42M derived: sum of 3 quarters · filed 2014-09-09 | $9.73M derived: sum of 4 quarters · filed 2014-09-09 | $93.60M 10-Q · filed 2013-02-12 | ||||||||||
| 2012-09-30 | $2.47M 10-Q · filed 2013-11-08 | $4.67M derived: sum of 2 quarters · filed 2014-09-09 | $6.97M derived: sum of 3 quarters · filed 2014-09-09 | $8.93M derived: sum of 4 quarters · filed 2014-09-09 | $90.84M 10-Q · filed 2012-11-13 | ||||||||||
| 2012-06-30 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-09 | $4.50M derived: sum of 2 quarters · filed 2014-09-09 | $6.46M derived: sum of 3 quarters · filed 2014-09-09 | $8.39M 10-K · filed 2014-09-09 | $88.37M 10-K · filed 2012-09-18 | ||||||||||
| 2012-03-31 | $2.30M 10-Q · filed 2013-05-09 | $4.26M derived: sum of 2 quarters · filed 2013-05-09 | $6.19M 10-Q · filed 2013-05-09 | $7.38M derived: sum of 4 quarters · filed 2013-05-09 | $86.17M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $1.96M 10-Q · filed 2012-02-09 | $3.89M 10-Q · filed 2013-02-12 | $5.08M derived: sum of 3 quarters · filed 2013-02-12 | $6.41M derived: sum of 4 quarters · filed 2013-02-12 | $83.87M 10-Q · filed 2012-02-09 | ||||||||||
| 2011-09-30 | $1.93M 10-Q · filed 2012-11-13 | $3.12M derived: sum of 2 quarters · filed 2012-11-13 | $4.45M derived: sum of 3 quarters · filed 2012-11-13 | $6.55M derived: sum of 4 quarters · filed 2012-11-13 | $81.91M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-18 | $2.52M derived: sum of 2 quarters · filed 2012-09-18 | $4.62M derived: sum of 3 quarters · filed 2012-09-18 | $6.45M 10-K · filed 2012-09-18 | |||||||||||
| 2011-03-31 | $1.33M 10-Q · filed 2012-05-15 | $3.43M derived: sum of 2 quarters · filed 2012-05-15 | $5.26M 10-Q · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $2.10M 10-Q · filed 2012-02-09 | $3.93M 10-Q · filed 2012-02-09 | |||||||||||||
| 2010-09-30 | $1.83M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |